Position
Associate Professor in the Department of Pharmacology at the University of Melbourne
Qualifications
• PhD (1986) Monash University
Expertise
• Cardiovascular pharmacology
• Mechanism of action of novel lead compounds
Key Areas of Research
• Investigation of novel angiotensin II receptor antagonists for the treatment of vascular disease.
• Cannabinoid receptor ligands and modified morphine derivatives in acute and neuropathic pain.
• The cardiovascular pharmacology of the venom from the jellyfish Malo maxima and its relation to Irukandji syndrome.
• Acute and chronic effects of methadone and buprenorphine on QTc prolongation and cardiac function.
Selected Publications
Wafai; Tudor; Angus, J; Wright, C. Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hindlimb ischemia. Journal of Vascular Research. 2009, 46, 45-54.
Sturgeon, S; Jones, C; Angus, J; Wright, C. Advantages of a selective β-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat. European Journal of Pharmacology. 2008, 587, 209-215.
